GC Biopharma Corp. 006280
KRX · South Korea · Health Technology
KRW 129,300.00+6,300.00 (+5.12%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-31 | 973.79 | 973.79 | 0.0% | KRW 421.20B | -3.3% | -0.8%KRW 114,200.00→KRW 113,300.00 |
| Q4 2024 | 2025-03-18 | -2,392.00 | -37.78 | -6,231.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.